Noah Labs website preview
seed medtech Berlin 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

Noah Labs develops AI-powered medical device software for remote patient monitoring and early detection of cardiac decompensation.

Classification

Berlin DE seed medtech saas b2b aiiot Health ManagementChronic CareTechnologyMonitoringData Analysis

Profile

Founded
2021
Tech stack
AI-powered heart detection algorithm, external device integration, implant integration

Funding

Funding details not yet available.

Compliance

MDR Class IIa

Fundraising & market

Regulatory
regulated
Business model
💡 Value Proposition

Enables early detection of cardiac decompensation via Vox algorithm and Ark telemonitoring to help patients live longer, healthier lives.

👥 Customer Segments

Healthcare systems and providers managing patients with chronic heart conditions requiring remote monitoring.

💰 Revenue Model

Ambiguous; likely SaaS for the AI agent or funding/donations for the healthcare nonprofit NOAH.

📡 Channels

Not specified in snippets for either the AI product or the healthcare organization.

🤝 Key Partnerships

No specific strategic alliances or partners are mentioned in the provided text.

⚖️ Cost Structure

No financial data provided for either the AI tool or the healthcare organization.

🏗️ Key Resources

Noah Labs Vox algorithm, Ark Class IIa Medical Device Software, and integration capabilities for external devices and implants.

⚙️ Key Activities

Developing AI-powered cardiac detection algorithms and maintaining Class IIa medical device software for seamless device integration.

💬 Customer Relationships

Not specified; implied high-touch support for clinical strategy and patient care.

Strategic analysis
🏁 Competitive landscape

Competes in remote cardiac monitoring with Vox as a key differentiator for early detection of cardiac decompensation.

🎯 Market pains

Lack of accessible remote monitoring for chronic conditions and delayed detection of cardiac decompensation in heart failure patients.

Team
CEO & Co-Founder
Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026